December 19, 2024 - 18:45
BOSTON & MONTREAL, December 19, 2024—enGene Holdings Inc., a clinical-stage genetic medicines company, has released its financial results for the full year 2024 alongside significant business updates. The company is advancing its lead investigational product, detalimogene voraplasmid, which is currently undergoing a pivotal study targeting patients with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) characterized by carcinoma in situ (CIS).
The financial report highlighted the company’s strategic investments in research and development, aimed at enhancing the efficacy of its therapeutic offerings. enGene's commitment to innovation in genetic medicine is evident as it continues to focus on pivotal clinical trials that could potentially transform treatment options for patients suffering from challenging forms of cancer.
In addition to its financial performance, enGene emphasized its ongoing efforts to strengthen partnerships and collaborations that will facilitate the advancement of its pipeline. The company remains optimistic about its future prospects and the potential impact of its therapies on patient outcomes.
June 18, 2025 - 01:57
Long-Time Sports Executive Takes Charge of Business Operations for Golden KnightsIn a significant move for the Vegas Golden Knights, a seasoned sports executive and dedicated hockey parent has stepped into the role of President of Business Operations. This appointment marks a...
June 17, 2025 - 11:52
Small Businesses Rally Behind New Tax LegislationIn a recent discussion on the impact of the latest tax rules, panelists Andrew Christ and Scott Holbrook highlighted how small businesses are embracing the newly proposed legislation, often...
June 16, 2025 - 18:52
Gene’s Fish Fry Honored with Historic Business DesignationGene’s Fish Fry, recently recognized as a historic business by the state, has proudly maintained its roots in East Greenbush amidst the rapid suburban development surrounding it. Established in...
June 16, 2025 - 03:04
The Unexpected Shifts in Business VenturesThere are countless examples of companies expanding into or outright pivoting to businesses that no one could’ve foreseen. In today`s rapidly evolving market, adaptability has become essential...